author-photo

Meike Vogler

University of Leicester

31

Papers

1964

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

2020 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (19)
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

2018 Cancers
Show All
- Source
- Cite
- Save
Citations (17)
Targeting anti‐apoptotic BCL2 family proteins in haematological malignancies – from pathogenesis to treatment

2017 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (47)
Targeting BCL2-Proteins for the Treatment of Solid Tumours

2014
- Meike Vogler
Show All
- Source
- Cite
- Save
Citations (58)
Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls.

2013 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (12)
ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets

2013 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (86)
Evaluation and critical assessment of putative MCL-1 inhibitors

2013 Cell Death & Differentiation
Show All
- Source
- Cite
- Save
Citations (85)
Response: BH3 mimetics modulate calcium homeostasis in platelets

2012 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Platelet toxicity induced by the BCL2-inhibitor ABT-263, a novel anti-cancer agent

2011 Toxicology
Show All
- Source
- Cite
- Save
Citations (0)
The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein

2011 Biochemical and Biophysical Research Communications
Show All
- Source
- Cite
- Save
Citations (16)